SeaStar Medical Holding Corp, trading under the ticker LMAO, is the post-merger successor to LMF Acquisition Opportunities Inc., a blank-check company sponsored by LMF Acquisition Holdings LLC that completed its IPO in 2021. The company operates in the medical device sector, focused on critical care technology targeting acute organ failure. SeaStar Medical filed an 8-K current report with the SEC on December 18, 2025, accession number 0001437749-25-038276, reflecting ongoing public-company reporting obligations following its de-SPAC transaction. The combined entity continues to trade on a U.S. national exchange. For complete filing history, sponsor details, and deal analytics on LMAO and hundreds of other SPACs, sign up for full data access at SpacDesk.